REG Stock Overview
Regis Healthcare Limited provides residential aged care services in Australia.
Regis Healthcare Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$1.88|
|52 Week High||AU$2.47|
|52 Week Low||AU$1.63|
|1 Month Change||-16.44%|
|3 Month Change||-12.15%|
|1 Year Change||-6.00%|
|3 Year Change||-28.52%|
|5 Year Change||-52.16%|
|Change since IPO||-53.23%|
Recent News & Updates
Regis Healthcare Limited's (ASX:REG) Intrinsic Value Is Potentially 34% Above Its Share Price
Does the February share price for Regis Healthcare Limited ( ASX:REG ) reflect what it's really worth? Today, we will...
|REG||AU Healthcare||AU Market|
Return vs Industry: REG underperformed the Australian Healthcare industry which returned -3.9% over the past year.
Return vs Market: REG exceeded the Australian Market which returned -12.2% over the past year.
|REG Average Weekly Movement||5.7%|
|Healthcare Industry Average Movement||5.2%|
|Market Average Movement||9.7%|
|10% most volatile stocks in AU Market||16.3%|
|10% least volatile stocks in AU Market||4.2%|
Stable Share Price: REG is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: REG's weekly volatility (6%) has been stable over the past year.
About the Company
Regis Healthcare Limited provides residential aged care services in Australia. It offers home care services, including personal hygiene, dressing and undressing, and mobility and transportation; home help services, such as cooking and cleaning, shopping and transportation, and facilitating social outings; aged care facilities; owns and operates specialist retirement and independent living villages, which provides laundry, meals, cleaning, and allied health services consist of physiotherapy, podiatry, diversional therapy, and therapeutic activities. The company also offers companionship and government-funded and private home care services; aged care services, including ageing-in-place, respite care, specialist dementia care, and palliative care services; in-home disability support and veterans’ home care services; Day Respite Programs for carers; and therapeutic services to people living in the community, in retirement villages, and aged care facilities.
Regis Healthcare Fundamentals Summary
|REG fundamental statistics|
Is REG overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|REG income statement (TTM)|
|Cost of Revenue||AU$583.96m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||0.026|
|Net Profit Margin||1.09%|
How did REG perform over the long term?See historical performance and comparison
4.3%Current Dividend Yield
Is REG undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 3/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for REG?
Other financial metrics that can be useful for relative valuation.
|What is REG's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does REG's PE Ratio compare to its peers?
|REG PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
EHE Estia Health
VRT Virtus Health
MVF Monash IVF Group
PSQ Pacific Smiles Group
REG Regis Healthcare
Price-To-Earnings vs Peers: REG is good value based on its Price-To-Earnings Ratio (72.9x) compared to the peer average (120.6x).
Price to Earnings Ratio vs Industry
How does REG's PE Ratio compare vs other companies in the Oceanian Healthcare Industry?
Price-To-Earnings vs Industry: REG is expensive based on its Price-To-Earnings Ratio (72.9x) compared to the Oceanic Healthcare industry average (22.5x)
Price to Earnings Ratio vs Fair Ratio
What is REG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||72.9x|
|Fair PE Ratio||43.7x|
Price-To-Earnings vs Fair Ratio: REG is expensive based on its Price-To-Earnings Ratio (72.9x) compared to the estimated Fair Price-To-Earnings Ratio (43.7x).
Share Price vs Fair Value
What is the Fair Price of REG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: REG (A$1.88) is trading below our estimate of fair value (A$4.86)
Significantly Below Fair Value: REG is trading below fair value by more than 20%.
Price to Earnings Growth Ratio
PEG Ratio: REG is poor value based on its PEG Ratio (2x)
Discover undervalued companies
How is Regis Healthcare forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Future Growth Score5/6
Future Growth Score 5/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: REG's forecast earnings growth (36% per year) is above the savings rate (1.8%).
Earnings vs Market: REG's earnings (36% per year) are forecast to grow faster than the Australian market (6.2% per year).
High Growth Earnings: REG's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: REG's revenue (5.6% per year) is forecast to grow faster than the Australian market (5.1% per year).
High Growth Revenue: REG's revenue (5.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: REG's Return on Equity is forecast to be very high in 3 years time (170.9%).
Discover growth companies
How has Regis Healthcare performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: REG has a large one-off gain of A$21.4M impacting its December 31 2021 financial results.
Growing Profit Margin: REG became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: REG's earnings have declined by 36% per year over the past 5 years.
Accelerating Growth: REG has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: REG has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (35.6%).
Return on Equity
High ROE: REG's Return on Equity (6.2%) is considered low.
Discover strong past performing companies
How is Regis Healthcare's financial position?
Financial Health Score2/6
Financial Health Score 2/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: REG's short term assets (A$68.4M) do not cover its short term liabilities (A$1.5B).
Long Term Liabilities: REG's short term assets (A$68.4M) do not cover its long term liabilities (A$150.5M).
Debt to Equity History and Analysis
Debt Level: REG's net debt to equity ratio (48.8%) is considered high.
Reducing Debt: REG's debt to equity ratio has reduced from 106.5% to 84.2% over the past 5 years.
Debt Coverage: REG's debt is well covered by operating cash flow (136.7%).
Interest Coverage: Insufficient data to determine if REG's interest payments on its debt are well covered by EBIT.
Discover healthy companies
What is Regis Healthcare current dividend yield, its reliability and sustainability?
Dividend Score 2/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: REG's dividend (4.34%) is higher than the bottom 25% of dividend payers in the Australian market (2.77%).
High Dividend: REG's dividend (4.34%) is low compared to the top 25% of dividend payers in the Australian market (6.9%).
Stability and Growth of Payments
Stable Dividend: REG has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: REG has only been paying a dividend for 7 years, and since then payments have fallen.
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (315.8%), REG's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (23.6%), REG's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Dr. Linda Jane Mellors, B.A., B.Sc. (Hons), Ph.D. (Med) GAICD, Grad Cert HSM, has been Chief Executive Officer of Regis Healthcare Limited since September 4, 2019 and serves as its Managing Director and Di...
CEO Compensation Analysis
Compensation vs Market: Linda's total compensation ($USD529.93K) is below average for companies of similar size in the Australian market ($USD891.35K).
Compensation vs Earnings: Linda's compensation has been consistent with company performance over the past year.
Experienced Management: REG's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Experienced Board: REG's board of directors are considered experienced (4.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Regis Healthcare Limited's employee growth, exchange listings and data sources
- Name: Regis Healthcare Limited
- Ticker: REG
- Exchange: ASX
- Founded: 1994
- Industry: Health Care Facilities
- Sector: Healthcare
- Implied Market Cap: AU$565.567m
- Shares outstanding: 300.83m
- Website: https://www.regis.com.au
Number of Employees
- Regis Healthcare Limited
- 615 Dandenong Road
- Level 2
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/06/24 00:00|
|End of Day Share Price||2022/06/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.